International Clinical Trial: A Phase III Open, extended, Multi-center Study to Evaluate the long-term Safety of ASC40 (Denifanstat) Tablets in Subjects With Moderate to Severe Acne Vulgaris

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126528) titled 'A Phase III Open, extended, Multi-center Study to Evaluate the long-term Safety of ASC40 (Denifanstat) Tablets in Subjects With Moderate to Severe Acne Vulgaris' on June 10.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Huashan Hospital, Fudan University

Condition: Moderate to severe acne vulgaris

Recruitment Status: Not Recruiting

Phase: 3

Date of First Enrollment: 2024-04-18

Target Sample Size: ASC40 (dinifastat) tablets 50 mg dose group:240;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=231188

Published by HT Digita...